Crystallization of paracetamol from solution in the presence and absence of impurity.
The bulk crystallization of paracetamol has been examined under controlled conditions in the presence and absence of the additive p-acetoxyacetanilide (PAA), as a function of both supersaturation and additive levels. The induction time to nucleation was found to increase with increase in PAA concentration in solution. The product micro-crystals were characterized for shape and strain/defect content using electron and optical microscopy and X-ray Laue diffraction techniques, respectively. A change in crystal habit of the pure crystals from columnar (dominant [110]) to plate-like (dominant [001]) was observed to occur with an increase in supersaturation level, whilst the addition of PAA invariably led to the development of columnar crystals with an aspect ratio that varied with impurity level and supersaturation. HPLC showed the PAA to be incorporated into the crystals with an average segregation coefficient of 14-18% depending on the supersaturation. The ready incorporation of PAA is attributed to the molecular similarity of this molecule to that of the host material. The incorporation is shown to cause a significant increase in the mosaic spread, implying the development of a significant strain/defect content in the crystals. The influence of the impurity on the time to nucleation is probably due to its effect in blocking the development of the critical nucleus. The potential implications of such variations in morphology and strain content in the design of the physical and chemical properties of the resulting particulates are discussed.
Tripartite Research Group, Department of Pure and Applied Chemistry, University of Strathclyde, 295 Catherdral Street, G1 1XL, Glasgow, UK.
K V
KV
Prasad
R I
RI
Ristic
D B
DB
Sheen
J N
JN
Sherwood
D000082:Acetaminophen / Q000737:chemistry*; D000083:Acetanilides / Q000737:chemistry; D003460:Crystallization; D004339:Drug Compounding; D004340:Drug Contamination; D008855:Microscopy, Electron, Scanning; D019999:Pharmaceutical Solutions
D000083:Acetanilides; D019999:Pharmaceutical Solutions; D000082:Acetaminophen